These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6161761)

  • 1. Pharmacokinetic factors governing the steady-state concentrations of foreign chemicals and their metabolites.
    Gillette JR
    Ciba Found Symp; 1980; 76():191-217. PubMed ID: 6161761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of foreign compounds on formation and disposition of reactive metabolites.
    Oesch F
    Ciba Found Symp; 1980; 76():169-89. PubMed ID: 6161760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of induction of cytochrome P-450 enzymes on the concentration of foreign compounds and their metabolites and on the toxicological effects of these compounds.
    Gillette JR
    Drug Metab Rev; 1979; 10(1):59-87. PubMed ID: 118860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolite pharmacokinetics: the area under the curve of metabolite and the fractional rate of metabolism of a drug after different routes of administration for renally and hepatically cleared drugs and metabolites.
    Pang KS
    J Pharmacokinet Biopharm; 1981 Aug; 9(4):477-87. PubMed ID: 7310645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The area under the curve of metabolites for drugs and metabolites cleared by the liver and extrahepatic organs. Its dependence on the administration route of precursor drug.
    Klippert PJ; Noordhoek J
    Drug Metab Dispos; 1985; 13(1):97-101. PubMed ID: 2858385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of decomposition of chemically unstable metabolites in the presence of nucleophiles: derivation of equations used in graphical analyses.
    Gillette JR
    Pharmacology; 1980; 20(2):64-86. PubMed ID: 7384191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the role of pharmacokinetics in integrating results from in vivo and in vitro studies.
    Gillette JR
    Food Chem Toxicol; 1986; 24(6-7):711-20. PubMed ID: 3781424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug metabolism by the human fetus.
    Juchau MR; Chao ST; Omiecinski CJ
    Clin Pharmacokinet; 1980; 5(4):320-39. PubMed ID: 6994979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental factors in drug metabolism.
    Gillette JR
    Fed Proc; 1976 Apr; 35(5):1142-7. PubMed ID: 1261708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats.
    Egorin MJ; Lagattuta TF; Hamburger DR; Covey JM; White KD; Musser SM; Eiseman JL
    Cancer Chemother Pharmacol; 2002 Jan; 49(1):7-19. PubMed ID: 11855755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of inducers on drug-metabolizing enzyme activity and on formation of reactive drug metabolites in the liver.
    Orrenius S; Thor H; Jernström B
    Ciba Found Symp; 1980; 76():25-42. PubMed ID: 6109599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dispersion model of hepatic elimination: 3. Application to metabolite formation and elimination kinetics.
    Roberts MS; Rowland M
    J Pharmacokinet Biopharm; 1986 Jun; 14(3):289-308. PubMed ID: 3783448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complicating factors in safety testing of drug metabolites: kinetic differences between generated and preformed metabolites.
    Prueksaritanont T; Lin JH; Baillie TA
    Toxicol Appl Pharmacol; 2006 Dec; 217(2):143-52. PubMed ID: 17055014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cytochrome P-450 and related enzymes in the pulmonary metabolism of xenobiotics.
    Philpot RM; Smith BR
    Environ Health Perspect; 1984 Apr; 55():359-67. PubMed ID: 6376107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-Silico Modeling in Drug Metabolism and Interaction: Current Strategies of Lead Discovery.
    Roy H; Nandi S
    Curr Pharm Des; 2019; 25(31):3292-3305. PubMed ID: 31481001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The P450 enzyme system: a key to understanding the metabolism of drugs.
    Bakutis AR
    AANA J; 1983 Jun; 51(3):272-4. PubMed ID: 6613503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Metabolism in the Liver.
    Almazroo OA; Miah MK; Venkataramanan R
    Clin Liver Dis; 2017 Feb; 21(1):1-20. PubMed ID: 27842765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological defence against xenobiotics at their portals of entry to the organism.
    Hänninen O; Aitio A; Hietanen E
    Med Biol; 1979 Oct; 57(5):251-5. PubMed ID: 392204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of covalent binding of chemically reactive metabolites of foreign compounds to proteins and lipids.
    Gillette JR
    Adv Exp Med Biol; 1986; 197():63-82. PubMed ID: 3766285
    [No Abstract]   [Full Text] [Related]  

  • 20. Pre- and postnatal enzyme capacity for drug metabolite production.
    Gillette JR; Stripp B
    Fed Proc; 1975 Feb; 34(2):172-8. PubMed ID: 1090453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.